To characterize the phenotypes of older adults with low lean mass and osteoporosis, concomitantly or isolated, in regards to poor physical performance and frailty status.
Cross-sectional analysis of the SARCopenia and OSteoporosis in Older Adults with Cardiovascular Diseases Study (SARCOS).
Outpatient geriatric cardiology clinic.
Participants and method
385 older adults underwent DXA analysis. Low lean mass was diagnosed according to FNIH and low BMD by a T-score ≤ −2.5 SD. Subjects were grouped into: I—Low lean mass and Osteoporosis (LLMO); II—Low lean mass (LLM); III—Osteoporosis (OP), and IV—Controls. Poor physical performance was diagnosed by weakness or slow walking speed or impaired mobility. Frailty was diagnosed by CHS criteria.
The mean age was 78.22 ± 7.16 years. The prevalence of LLMO, LLM, and OP were 14.8%, 39.5%, and 19.2%, respectively. LLMO subjects were older, predominantly women, with a high percentage of body fat (HTBF). LLM was represented by obese men, while individuals with OP were preferably women, older and leaner. In a regression analyses, LLMO presented an OR: 6.42 (2.63‒15.65; p < 0.001) for weakness, OR: 2.55 (1.09‒5.95; p = 0.030) for impaired mobility, and OR: 14.75 (2.72‒79.94; p = 0.002) for frailty. After adjusting for HTBF, the OR for frailty, decreased to 7.25 (1.11–47.21; p = 0.038). LLM and OP were associated only with weakness with an OR: 3.06 (1.36–6.84; p = 0.006) and OR: 3.14 (1.29–7.62; p = 0.011), respectively.
In Brazilian older community-dwelling outpatient adults, the phenotype characterized by low lean mass and osteoporosis presents a higher association with impaired mobility, weakness and frailty status compared to the others phenotyeps and controls. A high percentage of body fat presents a synergistic effect with low lean mass and osteoporosis phenotype in regards to frailty.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Shephard RJ. Age and physical work capacity. Exp Aging Res. 1999;25:331–43. https://doi.org/10.1080/036107399243788.
Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72:45 https://doi.org/10.1186/2049-3258-72-45.
Dempster DW. Osteoporosis and the burden of osteoporosis-related fractures. Am J Managed Care. 2011;17:S164–169.
Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, et al. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int. 2012;23:2863–71. https://doi.org/10.1007/s00198-012-1935-8.
Rikkonen T, Sirola J, Salovaara K, Tuppurainen M, Jurvelin JS, Honkanen R, et al. Muscle strength and body composition are clinical indicators of osteoporosis. Calcif Tissue Int. 2012;91:131–8. https://doi.org/10.1007/s00223-012-9618-1.
Laurent MR, Dubois V, Claessens F, Verschueren SM, Vanderschueren D, Gielen E, et al. Muscle-bone interactions: from experimental models to the clinic? A critical update. Mol Cell Endocrinol. 2016;432:14–36. https://doi.org/10.1016/j.mce.2015.10.017.
Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V. Muscle and bone, two interconnected tissues. Ageing Res Rev. 2015;21:55–70. https://doi.org/10.1016/j.arr.2015.03.002
Brotto M, Johnson ML. Endocrine crosstalk between muscle and bone. Curr Osteoporos Rep. 2014;12:135–41. https://doi.org/10.1007/s11914-014-0209-0.
Edwards MH, Gregson CL, Patel HP, Jameson KA, Harvey NC, Sayer AA, et al. Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. J Bone Min Res. 2013;28:2295–304. https://doi.org/10.1002/jbmr.1972
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. https://doi.org/10.1152/japplphysiol.00246.2003.
Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–81. https://doi.org/10.1093/ajcn/76.2.473.
Binkley N, Buehring B. Beyond FRAX: it’s time to consider “sarco-osteopenia”. J Clin Densitom. 2009;12:413–6. https://doi.org/10.1016/j.jocd.2009.06.004
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015;16:290–5. https://doi.org/10.1016/j.jamda.2014.10.018.
Crepaldi G, Maggi S. Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Invest. 2005;28:66–68.
Frisoli A Jr., Chaves PH, Ingham SJ, Fried LP. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women’s Health and Aging Study (WHAS) II. Bone. 2011;48:952–7. https://doi.org/10.1016/j.bone.2010.12.025.
Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P, et al. Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol. 2015;2015:482940 https://doi.org/10.1155/2015/482940.
Yoo JI, Kim H, Ha YC, Kwon HB, Koo KH. Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci. 2018;33:e27 https://doi.org/10.3346/jkms.2018.33.e27.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169.
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–58. https://doi.org/10.1093/gerona/glu010.
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. https://doi.org/10.1016/j.jamda.2013.11.025.
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series. WHO; 2000.894:i-xii–1-253.
World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Technical Report Series; 843. World Health Organization; 1994. p. 1–129.
Sjoblom S, Suuronen J, Rikkonen T, Honkanen R, Kroger H, Sirola J. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas. 2013;75:175–80. https://doi.org/10.1016/j.maturitas.2013.03.016.
Gonzalez-Montalvo JI, Alarcon T, Gotor P, Queipo R, Velasco R, Hoyos R, et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatrics Gerontol Int. 2016;16:1021–7. https://doi.org/10.1111/ggi.12590.
Yoshimura N, Muraki S, Oka H, Iidaka T, Kodama R, Kawaguchi H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int. 2017;28:189–99. https://doi.org/10.1007/s00198-016-3823-0.
Lamb SE, Keene DJ. Measuring physical capacity and performance in older people. Best Pract Res Clin Rheumatol. 2017;31:243–54. https://doi.org/10.1016/j.berh.2017.11.008.
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–94.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–156.
Stenholm S, Sallinen J, Koster A, Rantanen T, Sainio P, Heliovaara M, et al. Association between obesity history and hand grip strength in older adults–exploring the roles of inflammation and insulin resistance as mediating factors. J Gerontol A Biol Sci Med Sci. 2011;66:341–8. e-pub ahead of print 2011/02/12; glq226 [pii] https://doi.org/10.1093/gerona/glq226.
Hulens M, Vansant G, Lysens R, Claessens AL, Muls E, Brumagne S. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord. 2001;25:676–81. https://doi.org/10.1038/sj.ijo.0801560.
Cooper R, Hardy R, Bann D, Aihie Sayer A, Ward KA, Adams JE, et al. Body mass index from age 15 years onwards and muscle mass, strength, and quality in early old age: findings from the MRC National Survey of Health and Development. J Gerontol A Biol Sci Med Sci. 2014;69:1253–9. https://doi.org/10.1093/gerona/glu039.
Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14:362–6. https://doi.org/10.1007/s12603-010-0081-2.
Weinbrenner T, Schroder H, Escurriol V, Fito M, Elosua R, Vila J, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–35. https://doi.org/10.1093/ajcn/83.1.30.
Kanapuru B, Ershler WB. Inflammation, coagulation, and the pathway to frailty. Am J Med. 2009;122:605–13. https://doi.org/10.1016/j.amjmed.2009.01.030.
Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007;103:17–20. https://doi.org/10.1152/japplphysiol.00133.2007.
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914–20. https://doi.org/10.1038/nm.1964.
Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncog. 1998;9:99–106. https://doi.org/10.1615/critrevoncog.v9.i2.10.
Beyer I, Njemini R, Bautmans I, Demanet C, Bergmann P, Mets T. Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol. 2012;47:52–59. https://doi.org/10.1016/j.exger.2011.10.005.
Stenholm S, Strandberg TE, Pitkala KH, Sainio P, Heliovaara M, Koskinen S. Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: the Mini-Finland Follow-up Survey. J Gerontol A Biol Sci Med Sci. 2014;69:73–78. https://doi.org/10.1093/gerona/glt052.
Garcia-Esquinas E, Jose Garcia-Garcia F, Leon-Munoz LM, Carnicero JA, Guallar-Castillon P, Gonzalez-Colaco Harmand M, et al. Obesity, fat distribution, and risk of frailty in two population-based cohorts of older adults in Spain. Obes (Silver Spring). 2015;23:847–55. https://doi.org/10.1002/oby.21013.
Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Establishing the link between lean mass and grip strength cut-points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci. 2019. https://doi.org/10.1093/gerona/glz081.
Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Foger-Samwald U, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology. 2016;62:128–37. https://doi.org/10.1159/000431091.
Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J cachexia, sarcopenia muscle. 2018;9:3–19. https://doi.org/10.1002/jcsm.12238.
Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M. Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol. 2012;6:223–9.
Gorski J, Huffman NT, Brotto L, Dallas M , Breggia A, Chittur SV, Huang J, Mo C, Liu Y, Seidah NG, Rosen C, Brotto M, Bonewald L. Potential role of leptin and BMP2 in osteocyte regulation of muscle mass and function in the adult skeleton and with age. in: ASBMR 2013 Annual Meeting; October 4-7, 2013; Baltimore Convention Center. Baltimore, MD: American Society for Bone and Mineral Research; 2013.
Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102:919–25. https://doi.org/10.1152/japplphysiol.00627.2006.
Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB, Mohiti A. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J bone Miner Metab. 2014;32:400–4. https://doi.org/10.1007/s00774-013-0511-4.
Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011;54:1291–7. https://doi.org/10.1007/s00125-011-2155-z.
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R. Fi ATig. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016;28:895–9. https://doi.org/10.1007/s40520-015-0494-1.
Frisoli A Jr, Martin FC, Ingham SJ, Carvalho AC, Chaves P. The association of osteosarcopenia, sarcopenia and osteoporosis with weakness and mobility in older adults with cardiovascular disease: Data from Sarcos. Osteoporos Int. 2017;28:79 https://doi.org/10.1007/s00198-016-3530-x.
Greeves JP, Cable NT, Reilly T, Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci. 1999;97:79–84.
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci. 1993;84:95–98.
The authors would like to thank Tania Brunini Berna and Neusa Maria for help with the administrative aspects and organization of our study.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Frisoli Jr, A., Paes, A.T., Borges, J. et al. The association between low lean mass and osteoporosis increases the risk of weakness, poor physical performance and frailty in Brazilian older adults: data from SARCOS study. Eur J Clin Nutr (2020). https://doi.org/10.1038/s41430-020-00753-w